Hims & Hers Health stock price forecast: $27.61 resistance level as HIMS rises 3.74%

Traders Union
All News
Financial News
Hims & Hers Health up 3.74% today

Highlights

HIMS/USD shows a short- and medium-term bullish bias, but remains under long-term bearish pressure.
Strong intraday buying has pushed price to $27.17 with high volatility, though momentum signals remain mixed and conflicted.
Price is expected to range between $25.21 and $29.13 over the next 2–3 days, with a high probability of upward movement unless support fails.

Mixed momentum as momentum and resistance signals conflict

On the hourly chart, HIMS is above the MA-20 ($27.16) and MA-50 ($27.02), but remains below the long-term MA-200 ($33.89). The Ichimoku Kijun sits at $27.61, marking immediate resistance. MACD flashes strong sell momentum, while ADX remains neutral, signaling a lack of clear trend strength. RSI is near the midpoint at 52.26 with a buy reading, Stoch RSI is overbought, CCI is neutral, and BBP indicates strong buyer dominance intraday. Momentum indicators and oscillators give mixed signals, highlighting short-term bullish action with underlying uncertainty from conflicting technicals.

Upside outlook prevails if resistance breaks

Over the next 2–3 trading days, HIMS is expected to trade within a volatility band between $25.21 and $29.13. The probability of price moving higher is classified as very high, with a low likelihood of downward movement. The base scenario sees HIMS ranging in this corridor; a bullish outcome would require a confirmed breakout above the $27.61 resistance, while a bearish scenario could emerge if the price drops below the $25.21 support.

Anton Kharitonov, expert at Traders Union, sees HIMS displaying intraday bullish momentum but finds the technical outlook mixed. He notes conflicting indicators and the lack of notable news, which adds uncertainty to the short-term scenario. Kharitonov remains cautious, highlighting key levels at $27.61 and $25.21 for confirmation. "Base case remains rangebound — until resistance at $27.61 breaks, I stay defensive."

Earlier, analysts noted that Hims & Hers Health exhibited mixed technical signals, reflecting short-term bullishness tempered by caution over diverging momentum indicators. With intraday bullish momentum now prevailing but uncertainty persisting amid conflicting oscillator readings, an upside breakout above immediate resistance at $27.61 could catalyze increased volatility and shift market direction in the sessions ahead.

Source of Data: HIMS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.